Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Inglewood Ventures

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 6
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 3
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Therapeutics
  • Biotechnology
  • Medical
  • Medical Device
Summary

The venture was found in North America in United States. The main office of represented VC is situated in the San Diego.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Inglewood Ventures, startups are often financed by Sanderling Ventures, Life Sciences Partners, Biofrontier Partners. The meaningful sponsors for the fund in investment in the same round are Sanderling Ventures, Life Sciences Partners, GeneChem. In the next rounds fund is usually obtained by Sanderling Ventures, Bioventures Investors, Mitsui Global Investment.

This Inglewood Ventures works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Inglewood Ventures the average startup value is 100-500 millions dollars. The increased amount of exits for fund were in 2008. The important activity for fund was in 2001. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations.

Among the most popular fund investment industries, there are Pharmaceutical, Health Care. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Cylene Pharmaceuticals, Genicon Sciences, GeneFormatics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Inglewood Ventures:
Typical Co-investors
Inglewood Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Inglewood Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arena Capital Partners New York, New York, United States
Atom Factory California, Culver City, United States
Density Ventures Canada, Ontario, Toronto
East Chain Co. Cayman Islands, Midland
Edenred Capital Partners England, London, United Kingdom
Eir Partners -
FINANCIERE FONDS PRIVES France, Ile-de-France, Paris
Fucheng Touzi China, Guangdong Province, Guangzhou City
Hinsdale Durham, North Carolina, United States
Hongshi Capital Management Beijing, Beijing, China
Pendrell Corporation Kirkland, United States, Washington
Redmile Group California, San Francisco, United States
SAT Capital -
Shenzhen Qianhai Wanrong Hongtu Investment Fund China, Guangdong, Shenzhen
Techpeaks Italy, Trentino-Alto Adige, Trento
Tennessee Angel Fund -
Western Union Accelerator Powered by Techstars Colorado, Denver, United States
Windcrest Partners New York, New York, United States
Zhangjiagang Dagangcheng China, Jiangsu, Zhangjiagang
Zhengu Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

NewBiotics

Health Care
Medical
Therapeutics
$4M27 Apr 2004 San Diego, California, United States

CardioNet

Biotechnology
Health Care
Medical Device
$10M01 Mar 2004 Pennsylvania, United States

Therapeutics
$30M18 Sep 2003 San Diego, California, United States

Cylene Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$3M17 Oct 2001 San Diego, California, United States

NewBiotics

Health Care
Medical
Therapeutics
$11M25 Jul 2001 San Diego, California, United States

Advanced Materials
$32M06 Jun 2001 San Diego, California, United States

CardioNet

Biotechnology
Health Care
Medical Device
$6M01 May 2000 Pennsylvania, United States

NewBiotics

Health Care
Medical
Therapeutics
$6M04 Apr 2000 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Inglewood Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: